Brookline Capital Markets initiated coverage on Marker Therapeutics (NASDAQ:MRKR), a company focused on developing T cell-based immunotherapies for cancer, with a Buy rating and a 12-to-18-month price ...

Our focus in February is on companies and sectors that continue to see margin resilience and positive earnings trends.

Arthur Hayes remains bullish on Ethereum despite criticism, pointing to its strong developer base and institutional interest.

Simpson Manufacturing Company reported its fourth-quarter 2024 earnings, revealing an EPS of $1.31, falling short of the forecasted $1.55. Despite this, the company surpassed revenue expectations with ...

I’ve heard from many investors who are wondering about the fund from a portfolio perspective, asking if it makes sense to own both Invesco QQQ and a broad market index fund, such as Vanguard S&P 500 ...

Shipowners are growing uneasy, fearing that Trump’s suggestion of taking over Gaza could trigger a resurgence in Houthi ...

Walker isn't going to cost an arm and a leg, but he has shown enough potential to bring in some decent compensation. There's still a lot to work with here and a good coaching staff (like what the ...

US stocks (^DJI, ^IXIC, ^GSPC) ended Monday's trading session higher in positive territory in spite of any market headwinds ...

The price of gold is likely to hit $3,000 soon and perhaps $4,000 in 2026 as the central banks of countries hostile to the U.S. continue to accumulate it as a haven from U.S. sanctions. They've been ...

Tomm Pfitzenmaier, Summit Commodity Brokerage, says corn held its own on Monday and closed higher, squaring ahead of the February WASDE.

Treasury 2-year yields moved to 4.29% this week from 4.22% last week. At 10 years, this week’s yield is 4.49%, compared with ...

There is turmoil over looming US tariffs, there is only one week until the RBA decision, and ASIC takes on Star directors in ...